Ms Eva-lotta Allan
More than 25 years of business development experience from the biotechnology and life science industry in both private and public companies. Ms Allan has significant operational and investor relations expertise as well as board experience. She currently holds the position as Chief Business Officer at Immunocore Ltd, an immuno-oncology company specializing in the development of soluble T cell receptor based drugs. She has previously held senior positions at Ablynx, Vertex Pharmaceuticals, Oxford Asymmetry (now Evotec) and Oxford GlycoSciences (now UCB). Ms Allan holds a degree in microbiology from the University of Stockholm.